1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. UNITED THERAPEUTICS CORP

United Therapeutics Corp

XNAS: UTHR

Strong Performer, Under Radar
Download real time

296.64 3.18 (1.08%)

29.00% Fall from 52W High

19,655 XNAS Volume

XNAS 24 Apr, 2025 10:37 AM (EDT)

Watchlist

Portfolio

Share
14S
3W
2O
1T
13,322.7

Market Cap

High in industry
11.1

PE TTM

High in industry
0.5

PEG TTM

PEG TTM is less than 1
2.1

Price to Book

Below industry Median
-0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for United Therapeutics Corp is on 01 May 2025 for the purpose of United Therapeutics Corp First Quarter Earnings Results for 2025 See details

United Therapeutics Corp - UTHR - stock price prediction, stock price target, analyst ratings from 14 analysts

United Therapeutics Corp has a share price target of US$ 395, revenue growth forecast of 9.3%, and profit growth estimate of 11.5% for FY25, based on top 14 analyst calls.

Forecaster Screeners